0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dactinomycin Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-38W5742
Home | Market Reports | Science | Biological Sciences
Global Dactinomycin Market Insights and Forecast to 2028

Global Dactinomycin Market Insights and Forecast to 2028

Code: QYRE-Auto-38W5742
Report
May 2022
115 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Dactinomycin is a mixture of Streptomyces chrysomallus, mainly composed of C1, C2, C3 and D.Red or orange-yellow crystalline powder of madder.Soluble in ethanol, acetone and benzene.Its effect is similar to that of actinomycin, and it has a wide antitumor spectrum.In addition, also has the strong resistance bacteria, fungi and viruses.It is mainly used for Hodgkin's disease, nephroblastoma and leukemia in children.The toxic and side effects are similar to those of actinomycin, mainly myelosuppression and gastrointestinal reactions.Advanced malignant tumors, low red and white blood cells and pregnant women are contraindicated.
Market Analysis and Insights: Global Dactinomycin Market

The global Dactinomycin market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Injection accounting for % of the Dactinomycin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Alkylating Agent segment is altered to an % CAGR throughout this forecast period.
China Dactinomycin market size is valued at US$ million in 2021, while the North America and Europe Dactinomycin are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Dactinomycin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dactinomycin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dactinomycin market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dactinomycin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dactinomycin market.
Global Dactinomycin Scope and Market Size
Dactinomycin market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Dactinomycin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Injection
Implants

Segment by Application

Alkylating Agent
Hormone
Plant Medicine

BY COMPANY

AstraZeneca
GSK
Recordati Rare Diseases
Lundbeck
Merck
Prasco Laboratories
X-GEN Pharmaceuticals
Mylan Institutional
Bedford Pharmaceuticals
HISUN
Hainan Jinrui Pharmaceutical
Qilu Pharmaceutical
Shanghai Zhongke Pharmaceutical
Shanghai Xinya Pharmaceutical
Nantong Xinhe Biotechnology

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dactinomycin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Implants
1.3 Market by Application
1.3.1 Global Dactinomycin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alkylating Agent
1.3.3 Hormone
1.3.4 Plant Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Dactinomycin Market Perspective (2017-2028)
2.2 Dactinomycin Growth Trends by Region
2.2.1 Dactinomycin Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Dactinomycin Historic Market Size by Region (2017-2022)
2.2.3 Dactinomycin Forecasted Market Size by Region (2023-2028)
2.3 Dactinomycin Market Dynamics
2.3.1 Dactinomycin Industry Trends
2.3.2 Dactinomycin Market Drivers
2.3.3 Dactinomycin Market Challenges
2.3.4 Dactinomycin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dactinomycin Players by Revenue
3.1.1 Global Top Dactinomycin Players by Revenue (2017-2022)
3.1.2 Global Dactinomycin Revenue Market Share by Players (2017-2022)
3.2 Global Dactinomycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dactinomycin Revenue
3.4 Global Dactinomycin Market Concentration Ratio
3.4.1 Global Dactinomycin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dactinomycin Revenue in 2021
3.5 Dactinomycin Key Players Head office and Area Served
3.6 Key Players Dactinomycin Product Solution and Service
3.7 Date of Enter into Dactinomycin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dactinomycin Breakdown Data by Type
4.1 Global Dactinomycin Historic Market Size by Type (2017-2022)
4.2 Global Dactinomycin Forecasted Market Size by Type (2023-2028)
5 Dactinomycin Breakdown Data by Application
5.1 Global Dactinomycin Historic Market Size by Application (2017-2022)
5.2 Global Dactinomycin Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Dactinomycin Market Size (2017-2028)
6.2 North America Dactinomycin Market Size by Type
6.2.1 North America Dactinomycin Market Size by Type (2017-2022)
6.2.2 North America Dactinomycin Market Size by Type (2023-2028)
6.2.3 North America Dactinomycin Market Share by Type (2017-2028)
6.3 North America Dactinomycin Market Size by Application
6.3.1 North America Dactinomycin Market Size by Application (2017-2022)
6.3.2 North America Dactinomycin Market Size by Application (2023-2028)
6.3.3 North America Dactinomycin Market Share by Application (2017-2028)
6.4 North America Dactinomycin Market Size by Country
6.4.1 North America Dactinomycin Market Size by Country (2017-2022)
6.4.2 North America Dactinomycin Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Dactinomycin Market Size (2017-2028)
7.2 Europe Dactinomycin Market Size by Type
7.2.1 Europe Dactinomycin Market Size by Type (2017-2022)
7.2.2 Europe Dactinomycin Market Size by Type (2023-2028)
7.2.3 Europe Dactinomycin Market Share by Type (2017-2028)
7.3 Europe Dactinomycin Market Size by Application
7.3.1 Europe Dactinomycin Market Size by Application (2017-2022)
7.3.2 Europe Dactinomycin Market Size by Application (2023-2028)
7.3.3 Europe Dactinomycin Market Share by Application (2017-2028)
7.4 Europe Dactinomycin Market Size by Country
7.4.1 Europe Dactinomycin Market Size by Country (2017-2022)
7.4.2 Europe Dactinomycin Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dactinomycin Market Size (2017-2028)
8.2 Asia-Pacific Dactinomycin Market Size by Type
8.2.1 Asia-Pacific Dactinomycin Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Dactinomycin Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Dactinomycin Market Share by Type (2017-2028)
8.3 Asia-Pacific Dactinomycin Market Size by Application
8.3.1 Asia-Pacific Dactinomycin Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Dactinomycin Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Dactinomycin Market Share by Application (2017-2028)
8.4 Asia-Pacific Dactinomycin Market Size by Region
8.4.1 Asia-Pacific Dactinomycin Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Dactinomycin Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Dactinomycin Market Size (2017-2028)
9.2 Latin America Dactinomycin Market Size by Type
9.2.1 Latin America Dactinomycin Market Size by Type (2017-2022)
9.2.2 Latin America Dactinomycin Market Size by Type (2023-2028)
9.2.3 Latin America Dactinomycin Market Share by Type (2017-2028)
9.3 Latin America Dactinomycin Market Size by Application
9.3.1 Latin America Dactinomycin Market Size by Application (2017-2022)
9.3.2 Latin America Dactinomycin Market Size by Application (2023-2028)
9.3.3 Latin America Dactinomycin Market Share by Application (2017-2028)
9.4 Latin America Dactinomycin Market Size by Country
9.4.1 Latin America Dactinomycin Market Size by Country (2017-2022)
9.4.2 Latin America Dactinomycin Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dactinomycin Market Size (2017-2028)
10.2 Middle East & Africa Dactinomycin Market Size by Type
10.2.1 Middle East & Africa Dactinomycin Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Dactinomycin Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Dactinomycin Market Share by Type (2017-2028)
10.3 Middle East & Africa Dactinomycin Market Size by Application
10.3.1 Middle East & Africa Dactinomycin Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Dactinomycin Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Dactinomycin Market Share by Application (2017-2028)
10.4 Middle East & Africa Dactinomycin Market Size by Country
10.4.1 Middle East & Africa Dactinomycin Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Dactinomycin Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Dactinomycin Introduction
11.1.4 AstraZeneca Revenue in Dactinomycin Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Dactinomycin Introduction
11.2.4 GSK Revenue in Dactinomycin Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Recordati Rare Diseases
11.3.1 Recordati Rare Diseases Company Details
11.3.2 Recordati Rare Diseases Business Overview
11.3.3 Recordati Rare Diseases Dactinomycin Introduction
11.3.4 Recordati Rare Diseases Revenue in Dactinomycin Business (2017-2022)
11.3.5 Recordati Rare Diseases Recent Developments
11.4 Lundbeck
11.4.1 Lundbeck Company Details
11.4.2 Lundbeck Business Overview
11.4.3 Lundbeck Dactinomycin Introduction
11.4.4 Lundbeck Revenue in Dactinomycin Business (2017-2022)
11.4.5 Lundbeck Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Dactinomycin Introduction
11.5.4 Merck Revenue in Dactinomycin Business (2017-2022)
11.5.5 Merck Recent Developments
11.6 Prasco Laboratories
11.6.1 Prasco Laboratories Company Details
11.6.2 Prasco Laboratories Business Overview
11.6.3 Prasco Laboratories Dactinomycin Introduction
11.6.4 Prasco Laboratories Revenue in Dactinomycin Business (2017-2022)
11.6.5 Prasco Laboratories Recent Developments
11.7 X-GEN Pharmaceuticals
11.7.1 X-GEN Pharmaceuticals Company Details
11.7.2 X-GEN Pharmaceuticals Business Overview
11.7.3 X-GEN Pharmaceuticals Dactinomycin Introduction
11.7.4 X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2017-2022)
11.7.5 X-GEN Pharmaceuticals Recent Developments
11.8 Mylan Institutional
11.8.1 Mylan Institutional Company Details
11.8.2 Mylan Institutional Business Overview
11.8.3 Mylan Institutional Dactinomycin Introduction
11.8.4 Mylan Institutional Revenue in Dactinomycin Business (2017-2022)
11.8.5 Mylan Institutional Recent Developments
11.9 Bedford Pharmaceuticals
11.9.1 Bedford Pharmaceuticals Company Details
11.9.2 Bedford Pharmaceuticals Business Overview
11.9.3 Bedford Pharmaceuticals Dactinomycin Introduction
11.9.4 Bedford Pharmaceuticals Revenue in Dactinomycin Business (2017-2022)
11.9.5 Bedford Pharmaceuticals Recent Developments
11.10 HISUN
11.10.1 HISUN Company Details
11.10.2 HISUN Business Overview
11.10.3 HISUN Dactinomycin Introduction
11.10.4 HISUN Revenue in Dactinomycin Business (2017-2022)
11.10.5 HISUN Recent Developments
11.11 Hainan Jinrui Pharmaceutical
11.11.1 Hainan Jinrui Pharmaceutical Company Details
11.11.2 Hainan Jinrui Pharmaceutical Business Overview
11.11.3 Hainan Jinrui Pharmaceutical Dactinomycin Introduction
11.11.4 Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2017-2022)
11.11.5 Hainan Jinrui Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Dactinomycin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Dactinomycin Business (2017-2022)
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Shanghai Zhongke Pharmaceutical
11.13.1 Shanghai Zhongke Pharmaceutical Company Details
11.13.2 Shanghai Zhongke Pharmaceutical Business Overview
11.13.3 Shanghai Zhongke Pharmaceutical Dactinomycin Introduction
11.13.4 Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2017-2022)
11.13.5 Shanghai Zhongke Pharmaceutical Recent Developments
11.14 Shanghai Xinya Pharmaceutical
11.14.1 Shanghai Xinya Pharmaceutical Company Details
11.14.2 Shanghai Xinya Pharmaceutical Business Overview
11.14.3 Shanghai Xinya Pharmaceutical Dactinomycin Introduction
11.14.4 Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2017-2022)
11.14.5 Shanghai Xinya Pharmaceutical Recent Developments
11.15 Nantong Xinhe Biotechnology
11.15.1 Nantong Xinhe Biotechnology Company Details
11.15.2 Nantong Xinhe Biotechnology Business Overview
11.15.3 Nantong Xinhe Biotechnology Dactinomycin Introduction
11.15.4 Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2017-2022)
11.15.5 Nantong Xinhe Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Dactinomycin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Injection
    Table 3. Key Players of Implants
    Table 4. Global Dactinomycin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Dactinomycin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Dactinomycin Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Dactinomycin Market Share by Region (2017-2022)
    Table 8. Global Dactinomycin Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Dactinomycin Market Share by Region (2023-2028)
    Table 10. Dactinomycin Market Trends
    Table 11. Dactinomycin Market Drivers
    Table 12. Dactinomycin Market Challenges
    Table 13. Dactinomycin Market Restraints
    Table 14. Global Dactinomycin Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Dactinomycin Revenue Share by Players (2017-2022)
    Table 16. Global Top Dactinomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2021)
    Table 17. Ranking of Global Top Dactinomycin Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Dactinomycin Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Dactinomycin Product Solution and Service
    Table 21. Date of Enter into Dactinomycin Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Dactinomycin Revenue Market Share by Type (2017-2022)
    Table 25. Global Dactinomycin Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Dactinomycin Revenue Market Share by Type (2023-2028)
    Table 27. Global Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Dactinomycin Revenue Share by Application (2017-2022)
    Table 29. Global Dactinomycin Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Dactinomycin Revenue Share by Application (2023-2028)
    Table 31. North America Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Dactinomycin Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Dactinomycin Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Dactinomycin Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Dactinomycin Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Dactinomycin Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Dactinomycin Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Dactinomycin Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Dactinomycin Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Dactinomycin Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Dactinomycin Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Dactinomycin Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Dactinomycin Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Dactinomycin Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Dactinomycin Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Dactinomycin Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Dactinomycin Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Dactinomycin Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Dactinomycin Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Dactinomycin Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Dactinomycin Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Dactinomycin Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Dactinomycin Market Size by Country (2023-2028) & (US$ Million)
    Table 61. AstraZeneca Company Details
    Table 62. AstraZeneca Business Overview
    Table 63. AstraZeneca Dactinomycin Product
    Table 64. AstraZeneca Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 65. AstraZeneca Recent Developments
    Table 66. GSK Company Details
    Table 67. GSK Business Overview
    Table 68. GSK Dactinomycin Product
    Table 69. GSK Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 70. GSK Recent Developments
    Table 71. Recordati Rare Diseases Company Details
    Table 72. Recordati Rare Diseases Business Overview
    Table 73. Recordati Rare Diseases Dactinomycin Product
    Table 74. Recordati Rare Diseases Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 75. Recordati Rare Diseases Recent Developments
    Table 76. Lundbeck Company Details
    Table 77. Lundbeck Business Overview
    Table 78. Lundbeck Dactinomycin Product
    Table 79. Lundbeck Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 80. Lundbeck Recent Developments
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Dactinomycin Product
    Table 84. Merck Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 85. Merck Recent Developments
    Table 86. Prasco Laboratories Company Details
    Table 87. Prasco Laboratories Business Overview
    Table 88. Prasco Laboratories Dactinomycin Product
    Table 89. Prasco Laboratories Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 90. Prasco Laboratories Recent Developments
    Table 91. X-GEN Pharmaceuticals Company Details
    Table 92. X-GEN Pharmaceuticals Business Overview
    Table 93. X-GEN Pharmaceuticals Dactinomycin Product
    Table 94. X-GEN Pharmaceuticals Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 95. X-GEN Pharmaceuticals Recent Developments
    Table 96. Mylan Institutional Company Details
    Table 97. Mylan Institutional Business Overview
    Table 98. Mylan Institutional Dactinomycin Product
    Table 99. Mylan Institutional Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 100. Mylan Institutional Recent Developments
    Table 101. Bedford Pharmaceuticals Company Details
    Table 102. Bedford Pharmaceuticals Business Overview
    Table 103. Bedford Pharmaceuticals Dactinomycin Product
    Table 104. Bedford Pharmaceuticals Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 105. Bedford Pharmaceuticals Recent Developments
    Table 106. HISUN Company Details
    Table 107. HISUN Business Overview
    Table 108. HISUN Dactinomycin Product
    Table 109. HISUN Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 110. HISUN Recent Developments
    Table 111. Hainan Jinrui Pharmaceutical Company Details
    Table 112. Hainan Jinrui Pharmaceutical Business Overview
    Table 113. Hainan Jinrui Pharmaceutical Dactinomycin Product
    Table 114. Hainan Jinrui Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 115. Hainan Jinrui Pharmaceutical Recent Developments
    Table 116. Qilu Pharmaceutical Company Details
    Table 117. Qilu Pharmaceutical Business Overview
    Table 118. Qilu Pharmaceutical Dactinomycin Product
    Table 119. Qilu Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 120. Qilu Pharmaceutical Recent Developments
    Table 121. Shanghai Zhongke Pharmaceutical Company Details
    Table 122. Shanghai Zhongke Pharmaceutical Business Overview
    Table 123. Shanghai Zhongke Pharmaceutical Dactinomycin Product
    Table 124. Shanghai Zhongke Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 125. Shanghai Zhongke Pharmaceutical Recent Developments
    Table 126. Shanghai Xinya Pharmaceutical Company Details
    Table 127. Shanghai Xinya Pharmaceutical Business Overview
    Table 128. Shanghai Xinya Pharmaceutical Dactinomycin Product
    Table 129. Shanghai Xinya Pharmaceutical Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 130. Shanghai Xinya Pharmaceutical Recent Developments
    Table 131. Nantong Xinhe Biotechnology Company Details
    Table 132. Nantong Xinhe Biotechnology Business Overview
    Table 133. Nantong Xinhe Biotechnology Dactinomycin Product
    Table 134. Nantong Xinhe Biotechnology Revenue in Dactinomycin Business (2017-2022) & (US$ Million)
    Table 135. Nantong Xinhe Biotechnology Recent Developments
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dactinomycin Market Share by Type: 2021 VS 2028
    Figure 2. Injection Features
    Figure 3. Implants Features
    Figure 4. Global Dactinomycin Market Share by Application: 2021 VS 2028
    Figure 5. Alkylating Agent Case Studies
    Figure 6. Hormone Case Studies
    Figure 7. Plant Medicine Case Studies
    Figure 8. Dactinomycin Report Years Considered
    Figure 9. Global Dactinomycin Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Dactinomycin Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Dactinomycin Market Share by Region: 2021 VS 2028
    Figure 12. Global Dactinomycin Market Share by Players in 2021
    Figure 13. Global Top Dactinomycin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dactinomycin as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Dactinomycin Revenue in 2021
    Figure 15. North America Dactinomycin Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Dactinomycin Market Size Market Share by Type (2017-2028)
    Figure 17. North America Dactinomycin Market Size Market Share by Application (2017-2028)
    Figure 18. North America Dactinomycin Market Size Share by Country (2017-2028)
    Figure 19. United States Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Dactinomycin Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Dactinomycin Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Dactinomycin Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Dactinomycin Market Size Share by Country (2017-2028)
    Figure 25. Germany Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Dactinomycin Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Dactinomycin Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Dactinomycin Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Dactinomycin Market Size Share by Region (2017-2028)
    Figure 35. China Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Dactinomycin Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Dactinomycin Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Dactinomycin Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Dactinomycin Market Size Share by Country (2017-2028)
    Figure 45. Mexico Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Dactinomycin Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Dactinomycin Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Dactinomycin Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Dactinomycin Market Size Share by Country (2017-2028)
    Figure 51. Turkey Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Dactinomycin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. AstraZeneca Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 55. GSK Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 56. Recordati Rare Diseases Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 57. Lundbeck Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 59. Prasco Laboratories Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 60. X-GEN Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 61. Mylan Institutional Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 62. Bedford Pharmaceuticals Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 63. HISUN Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 64. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 65. Qilu Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 66. Shanghai Zhongke Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 67. Shanghai Xinya Pharmaceutical Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 68. Nantong Xinhe Biotechnology Revenue Growth Rate in Dactinomycin Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global and United States Human Microbiome Modulators Market Report Forecast 2022 2028
Global and United States Human Microbiome Modulators Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-30P5716
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States DNA Sequencing Technologies Market Report Forecast 2022 2028
Global and United States DNA Sequencing Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-28Y5798
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Genetic Modification Market Report Forecast 2022 2028
Global and United States Genetic Modification Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-29Q5817
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart